Nasdaq · CIK 0001910139
MBLY Mobileye Global Inc.
Insider trading from SEC Form 4. Last filing Dec 9, 2024.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
5
with a Form 4 at this company
Signals
Open-market buys and sells at Mobileye Global Inc., scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 28Weak | buy | GELSINGER PATRICK P director | $101k | 6,750 | +5% | - |
Transactions
The last 7 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 5, 2024 | Chao Elaine L. director | AGrant or award Class A Common Stock | +12,619 | $0.00 | $0 | 19,796 | Dec 9, 2024 |
| Dec 5, 2024 | Desheh Eyal director | AGrant or award Class A Common Stock | +12,619 | $0.00 | $0 | 37,328 | Dec 9, 2024 |
| Dec 5, 2024 | McCaskill Claire C. director | AGrant or award Class A Common Stock | +12,619 | $0.00 | $0 | 68,328 | Dec 9, 2024 |
| Dec 5, 2024 | Yeary Frank D director | AGrant or award Class A Common Stock | +12,619 | $0.00 | $0 | 54,828 | Dec 9, 2024 |
| Nov 13, 2024 | GELSINGER PATRICK P director | JOther Class A Common Stockindirect: By GRAT | +139,456 | $0.00 | $0 | 139,456 | Nov 15, 2024 |
| Nov 13, 2024 | GELSINGER PATRICK P director | JOther Class A Common Stockindirect: By Trust | -139,456 | $0.00 | $0 | 0 | Nov 15, 2024 |
| Nov 4, 2024 | GELSINGER PATRICK P director | POpen-market purchase Class A Common Stockindirect: By Trust | +6,750 | $14.94 | $101k | 139,456 | Nov 6, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Chao Elaine L.director
- Desheh Eyaldirector
- GELSINGER PATRICK Pceo, officer, director
- McCaskill Claire C.director
- Yeary Frank Ddirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.